Client News

Home/Client News
Client News 2018-08-28T11:24:45+00:00
May 4, 2017
Minerva Neurosciences Reports First Quarter 2017 Financial Results and Business Updates
WALTHAM, Mass., May 04, 2017 (GLOBE NEWSWIRE) -- Minerva Neurosciences, Inc. (NERV), a clinical-stage biopharmaceutical company focused on the development of therapies to treat central ...
May 4, 2017
Rockwell Medical Mails Letter to Shareholders Profiling Independent Director Nominee David Domzalski
WIXOM, Mich., May 04, 2017 (GLOBE NEWSWIRE) -- Rockwell Medical, Inc. (NASDAQ:RMTI) today mailed a letter to its shareholders in connection with the Company's upcoming ...
May 4, 2017
Onconova Therapeutics, Inc. to Provide Corporate Update and First Quarter 2017 Financial Results
NEWTOWN, Pa., May 04, 2017 (GLOBE NEWSWIRE) -- Onconova Therapeutics, Inc. (NASDAQ:ONTX), a Phase 3 stage biopharmaceutical company focused on discovering and developing novel products ...
May 4, 2017
Rexahn Pharmaceuticals Reports First Quarter 2017 Financial Results and Provides Corporate Update
ROCKVILLE, Md., May 04, 2017 (GLOBE NEWSWIRE) -- Rexahn Pharmaceuticals, Inc. (NYSE MKT:<a href="http://www.nasdaq.com/symbol/rnn">RNN</a>), a clinical stage biopharmaceutical company developing innovative, targeted therapeutics for the ...
May 4, 2017
Immune Pharmaceuticals Announces Private Placement of up to $3.4 Million Read more: http://www.nasdaq.com/press-release/immune-pharmaceuticals-announces-private-placement-of-up-to-34-million-20170504-01088#ixzz4g7TwxwKz
NEW YORK, May 4, 2017 /PRNewswire/ -- Immune Pharmaceuticals Inc. (Nasdaq:IMNP) ("Immune" or the "Company") today announced that it has entered into definitive agreements with several ...
May 3, 2017
LifeSci Advisors Expands Corporate Access Team with Appointment of Tara Hartigan
NEW YORK, May 03, 2017 (GLOBE NEWSWIRE) -- LifeSci Advisors, LLC (the "Company" or "LifeSci"), the leading international investor relations and corporate communications firm dedicated ...
May 2, 2017
Revolt Against Sky-High Drug Prices Prompts a Pioneer to Cash Out
Entrepreneur Jeffrey Aronin said a few years ago he hoped to eventually sell Marathon Pharmaceuticals LLC, which he controls and runs, for billions of dollars, ...
May 2, 2017
Perrigo Says Investigators Searched Its Offices in Generic-Drug Probe
Perrigo Co. PRGO -5.09% said Tuesday its offices were searched by investigators conducting a federal probe of price collusion in the generic-drug industry. ...
Page 117 of 117